Corsair Gaming, Inc. is a privately owned American company founded in 1994. Its headquarters are located in the United States. The company manufactures and sells computer peripherals and hardware.
Corsair Pharma completed preclinical studies on July 26 for its transdermal treprostinil prodrug system, TRX-248, supporting its advancement to human trials for pulmonary arterial hypertension treatment. The preclinical program showed steady-state treprostinil concentrations and an acceptable safety profile in minipig models. Separately, HTF Market Intelligence published a research document on the SSD for Gaming Market, offering insights to 2031, and also released a Global Computer Fan Market Study providing a comprehensive analysis for 2025-2032. An Amazon deal reduced the price of Corsair’s K70 Pro Mini keyboard to $84.99.